These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17190951)

  • 1. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.
    Cano SJ; Hobart JC; Edwards M; Fitzpatrick R; Bhatia K; Thompson AJ; Warner TT
    Neurology; 2006 Dec; 67(12):2230-2. PubMed ID: 17190951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
    Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
    Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
    Tarsy D
    Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
    Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
    J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache in cranial and cervical dystonia.
    Barbanti P; Fabbrini G; Pauletti C; Defazio G; Cruccu G; Berardelli A
    Neurology; 2005 Apr; 64(7):1308-9. PubMed ID: 15824376
    [No Abstract]   [Full Text] [Related]  

  • 7. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
    Dressler D; Kupsch A; Seitzinger A; Paus S
    Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
    Factor SA; Molho ES; Evans S; Feustel PJ
    Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inter-rater reliability while using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in patients with cervical dystonia].
    Kaji R; Osawa M; Yanagisawa N
    Brain Nerve; 2009 Jan; 61(1):65-71. PubMed ID: 19177808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of botulinum toxin for cervical dystonia. A comparison of methods for evaluation.
    Odergren T; Tollbäck A; Borg J
    Scand J Rehabil Med; 1994 Dec; 26(4):191-5. PubMed ID: 7878393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiotherapy in cervical dystonia: six experimental single-case studies.
    Zetterberg L; Halvorsen K; Färnstrand C; Aquilonius SM; Lindmark B
    Physiother Theory Pract; 2008; 24(4):275-90. PubMed ID: 18574753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal clinically important change in the Toronto Western Spasmodic Torticollis Rating Scale.
    Espay AJ; Trosch R; Suarez G; Johnson J; Marchese D; Comella C
    Parkinsonism Relat Disord; 2018 Jul; 52():94-97. PubMed ID: 29530726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrocollis: classification, clinical phenotype, treatment outcomes and risk factors.
    Papapetropoulos S; Baez S; Zitser J; Sengun C; Singer C
    Eur Neurol; 2008; 59(1-2):71-5. PubMed ID: 17917462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Canadian multicentre study of deep brain stimulation for cervical dystonia.
    Kiss ZH; Doig-Beyaert K; Eliasziw M; Tsui J; Haffenden A; Suchowersky O; ;
    Brain; 2007 Nov; 130(Pt 11):2879-86. PubMed ID: 17905796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis.
    Veehof MM; ten Klooster PM; Taal E; van Riel PL; van de Laar MA
    J Rheumatol; 2008 Apr; 35(4):610-7. PubMed ID: 18322989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (Dysport
    Simonetta-Moreau M; Picaut P; Volteau M; Poewe W
    Eur J Neurol; 2019 Jun; 26(6):943-e65. PubMed ID: 30168896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the burden of illness from cervical dystonia using the Toronto Western Spasmodic Torticollis Rating Scale scores and health utility: a meta-analysis of baseline patient-level clinical trial data.
    Jen MH; Kurth H; Iheanacho I; Dinet J; Gabriel S; Wasiak R; Jost WH
    J Med Econ; 2014 Nov; 17(11):803-9. PubMed ID: 25155368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
    Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
    Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cervical dystonia: a comparison of measures for outcome assessment.
    Lindeboom R; Brans JW; Aramideh M; Speelman HD; De Haan RJ
    Mov Disord; 1998 Jul; 13(4):706-12. PubMed ID: 9686779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.